Faron Pharmaceuticals Oy (LON:FARN) Shares Cross Below 50 Day Moving Average – Time to Sell?

Faron Pharmaceuticals Oy (LON:FARN) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 181.45 ($2.29) and traded as low as GBX 165 ($2.08). Faron Pharmaceuticals Oy shares last traded at GBX 171.40 ($2.16), with a volume of 5,593 shares changing hands.

Faron Pharmaceuticals Oy Trading Down 1.6 %

The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09. The stock has a market cap of £224.54 million, a price-to-earnings ratio of -4.47 and a beta of 0.36. The company’s fifty day moving average price is GBX 181.45 and its 200-day moving average price is GBX 186.95.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.